Italia markets closed

TEVA Jul 2024 18.500 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,36000,0000 (0,00%)
In data: 01:16PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente1,3600
ApertoN/D
Denaro1,6500
Domanda2,7000
Prezzo d'esercizio18,50
Scadenza2024-07-12
Min-Max giorno1,3600 - 1,3600
Contratto - Min-MaxN/D
VolumeN/D
Open Interest10
  • GlobeNewswire

    Teva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership

    TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.